At AMCP 2019, Cate Lockhart, MS, PharmD, PhD, executive director at Biologics and Biosimilars Collective Intelligence Consortium, discusses accelerating the uptake of biosimilars in the U.S. market.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

AMCP 2019 Street Team: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium

Newsletter